Skip to main content
YDES logo

YD Bio Limited

YDESNASDAQHealthcareBiotechnology

$5.92Today:- (-)1Y −66.45%

As of Oct 16, 2026 close

Market cap
$477.38M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.70$22.00
Volume (live)
-
Avg. volume (3M)
502.64K

YD Bio (YDES) Company Profile

Complete business overview, executive team, trading details, and corporate information.

YD Bio Limited
YDES•Nasdaq Stock Market•Healthcare•Biotechnology

About YD Bio

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOEthan Shen
Founded2013
CountryTaiwan
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitewww.ydesgroup.com
Address
No. 3, Xingnan St., 12F. Taipei, 115001 Taiwan

Corporate Identifiers

CIK0002011674
CUSIPG98301107
ISINKYG983011076
SIC8071

Leadership Team & Key Executives

Dr. Ethan Shen Ph.D.
Chief Executive Officer and Chairman
Edmund Hen CPA, F.C.A., M.S.
Chief Financial Officer
Dr. Benjamin Zhang M.D.
Chief Medical Officer and Director